Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites

Journal of Comparative Neurology

Volumn 475, Issue 1, 2004, Pages 19-35

  Kalamatianos, Theodosis ^a   Kalló, Imre ^a,b   Piggins, Hugh D ^c   Coen, Clive W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Circadian; Hypothalamic paraventricular nucleus; Somatostatin; Thalamic paraventricular nucleus; Vasopressin

Indexed keywords

ARGIPRESSIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; AUTOREGULATION; BINDING SITE; CELL POPULATION; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIENCEPHALON; EFFERENT NERVE; IMMUNOREACTIVITY; INCIDENCE; MALE; MAMMAL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA CELL; SUPRACHIASMATIC NUCLEUS;

ANIMALS; EFFERENT PATHWAYS; GENE EXPRESSION REGULATION; MALE; PEPTIDE BIOSYNTHESIS; RATS; RATS, WISTAR; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RNA, MESSENGER; SUPRACHIASMATIC NUCLEUS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 2642526031     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20168     Document Type: Article

References (114)

1. Aguilar-Roblero R, Morin LP, Moore RY. 1994. Morphological correlates of circadian rhythm restoration induced by transplantation of the suprachiasmatic nucleus in hamsters. Exp Neurol 130:250-260.
2. Albers HE, Stopa EG, Zoeller RT, Kauer JS, King JC, Fink JS, Mobtaker H, Wolfe H. 1990. Day-night variation in prepro vasoactive intestinal peptide/peptide histidine isoleucine mRNA within the rat suprachiasmatic nucleus. Brain Res Mol Brain Res 7:85-89.
3. Alexander LD, Sander LD. 1995. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Neuropeptides 28:167-173.
4. Arima H, House SB, Gainer H, Aguilera G. 2002. Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 143:4165-4171.
5. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. 2001. A neural circuit for circadian regulation of arousal. Nat Neurosci 4:732-738.
6. Berendse HW, Groenewegen HJ. 1990. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 299:187-228.
7. Boer GJ, van Esseveldt KE, Dijkhuizen PA, Hermens WT, te Beek ET, Van Heerikhuize JJ, Poldervaart HA, Verhaagen J. 2001. Adenoviral vector-mediated expression of neurotrophin-3 increases neuronal survival in suprachiasmatic nucleus grafts. Exp Neurol 169:364-375.
8. Buijs RM, Markman M, Nunes-Cardoso B, Hou YX, Shinn S. 1993. Projections of the suprachiasmatic nucleus to stress-related areas in the rat hypothalamus: a light and electron microscopic study. J Comp Neurol 335:42-54.
9. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MG, Ter Horst GJ, Romijn HJ, Kalsbeek A. 1999. Anatomical and functionl demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 11:1535-1544.
10. Cagampang FR, Piggins HD, Sheward WJ, Harmar AJ, Coen CW. 1998a. Circadian changes in PACAP type 1 (PAC1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei. Brain Res 813:218-222.
11. Cagampang FR, Sheward WJ, Harmar AJ, Piggins HD, Coen CW. 1998b. Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei. Brain Res Mol Brain Res 54:108-112.
12. Card JP, Brecha N, Karten HJ, Moore RY. 1981. Immunocytochemical localizaation of vasoactive intestinal polypeptide-containing cells and processes in the suprachiasmatic nucleus of the rat: light and electron microscope analysis. J Neurosci 1:1289-1303.
13. Chatterjee TK, Sharma RV, Fisher RA. 1996. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation L-type calcium channels. J Biol Chem 271:32226-32232.
14. Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J. 2003. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 23: 10691-10702.
15. Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelievre V, Hu Z, Liu X, Waschek JA. 2003. Disrupted circadian rhythms in VIP and PHI deficient mice. Am J Physiol Regul Integr Comp Physiol 285:939-949.
16. Cutler DJ, Haraura M, Reed HE, Shen S, Sheward WJ, Morrison CF, Marston HM, Harmar AJ, Piggins HD. 2003. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro. Eur J Neurdsci 17:197-204.
17. Daikoku S, Hisano S, Kagotani Y. 1992. Neuronal associations in the rat suprachiasmatic nucleus demonstrated by immunoelectron microscopy. J Comp Neurol 325:559-571.
18. Dardente H, Poirel VJ, Klosen P, Pevet P, Masson-Pevet M. 2002. Per and neuropeptide expression in the rat suprachiasmatic nuclei: compartmentalization and differential cellular induction by light. Brain Res 958:261-271.
19. Dziema H, Obrietan K. 2002. PACAP potentiates L-type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway. J Neurophysiol 88:1374-1386.
20. Fukuhara C, Shinohara K, Tominaga K, Otori Y, Inouye ST. 1993. Endogenous circadian rhythmicity of somatostatin like-immunoreactivity in the rat suprachiasmatic nucleus. Brain Res 606:28-35.
21. Fukuhara C, Nishiwaki T, Cagampang FR, Inouye ST. 1994. Emergence of VIP rhythmicity following somatostatin depletion in the rat suprachiasmatic nucleus. Brain Res 645:343-346.
22. Gooley JJ, Lu J, Fischer D, Saper CB. 2003. A broad role for melanopsin in nonvisual photoreception. J Neurosci 23:7093-7106.
23. Hahm SH, Eiden LE. 1998. Five discrete cis-active domains direct cell type-specific transcription of the vasoactive intestinal peptide (VIP) gene. J Biol Chem 273:17086-17094.
24. Hamada T, LeSauter J, Venuti JM, Silver R. 2001. Expression of Period genes: rhythmic and nonrhythmic compartments of the suprachiasmatic nucleus pacemaker. J Neurosci 21:7742-7750.
25. Hannibal J. 2002. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res 309:73-88.
26. Hannibal J, Ding JM, Chen D, Fahrenkrug J, Larsen PJ, Gillette MU, Mikkelsen JD. 1997. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci 17:2637-2644.
27. Hannibal J, Moller M, Ottersen OP, Fahrenkrug J. 2000. PACAP and glutamate are co-stored in the retinohypothalamic tract. J Comp Neurol 418:147-155.
28. Hannibal J, Jamen F, Nielsen HS, Journot L, Brabet P, Fahrenkrug J. 2001. Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J Neurosci 21: 4883-4890.
29. Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J. 2002. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 22:RC191.
30. Harmar AJ. 2003. An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei. J Neuroendocrinol 15:335-338.
31. Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH. 2002. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 109:497-508.
32. Harrington ME, Hoque S, Hall A, Golombek D, Biello S. 1999. Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J Neurosci 19:6637-6642.
33. Hastings MH, Duffield GE, Smith EJ, Maywood ES, Ebling FJ. 1998. Entrainment of the circadian system of mammals by nonphotic cues. Chronobiol Int 15:425-445.
34. Hisano S, Chikamori-Aoyama M, Katoh S, Kagotani Y, Daikoku S, Chihara K. 1988. Suprachiasmatic nucleus neurons immunoreactive for vasoactive intestinal polypeptide have synaptic contacts with axons immunoreactive for neuropeptide Y: an immunoelectron microscopic study in the rat. Neurosci Lett 88:145-150.
35. Hrabovszky E, Shughrue PJ, Merchenthaler I, Hajszan T, Carpenter CD, Liposits Z, Petersen SL. 2000. Detection of estrogen receptor-beta messenger ribonucleic acid and 125I-estrogen binding sites in luteinizing hormone-releasing hormone neurons of the rat brain. Endocrinology 141:3506-3509.
36. Ibata Y, Takahashi Y, Okamura H, Kawakami F, Terubayashi H, Kubo T, Yanaihara N. 1989. Vasoactive intestinal peptide (VIP)-like immunoreactive neurons located in the rat suprachiasmatic nucleus receive a direct retinal projection. Neurosci Lett 97:1-5.
37. Ibata Y, Tanaka M, Ichitani Y, Takahashi Y, Okamura H. 1993. Neuronal interaction between VIP and vasopressin neurones in the rat suprachiasmatic nucleus. Neuroreport 4:128-130.
38. Isobe Y, Nishino H. 1996. Vasoactive intestinal peptide and gastrin-releasing peptide play distinct roles in the suprachiasmatic nucleus. Brain Res Bull 40:287-90.
39. Itri J, Colwell CS. 2003. Regulation of inhibitory synaptic transmission by vasoactive intestinal peptide (VIP) in the mouse suprachiasmatic nucleus. J Neurophysiol 90:1589-1597.
40. Jacomy H, Burlet A, Bosler O. 1999. Vasoactive intestinal peptide neurons as synaptic targets for vasopressin neurons in the suprachiasmatic nucleus. Double-label immunocytochemical demonstration in the rat. Neuroscience 88:859-870.
41. Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM. 1999. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 96:57-68.
42. Kalsbeek A, Buijs RM. 2002. Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting. Cell Tissue Res 309:109-118.
43. Kalsbeek A, Fliers E, Franke AN, Wortel J, Buijs RM. 2000. Functional connections between the suprachiasmatic nucleus and the thyroid gland as revealed by lesioning and viral tracing techniques in the rat. Endocrinology 141:3832-3841.
44. Kawaguchi C, Tanaka K, Isojima Y, Shintani N, Hashimoto H, Baba A, Nagai K. 2003. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem Biophys Res Commun 310: 169-175.
45. Kerner JA, Standaert DG, Penney JB Jr, Young AB, Landwehrmeyer GB. 1998. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Res Brain Res Protoc 3:22-32.
46. Kim JK, Summer SN, Wood WM, Schrier RW. 2001. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochem Biophys Res Commun 289:1252-1256.
47. King VM, Chahad-Ehlers S, Shen S, Harmar AJ, Maywood ES, Hastings MH. 2003. A hVIPR transgene as a novel tool for the analysis of circadian function in the mouse suprachiasmatic nucleus. Eur J Neurosci 17:822-832.
48. Kopp M, Meissl H, Korf HW. 1997. The pituitary adenylate cyclase-activating polypeptide-induced phosphorylation of the transcription factor CREB (cAMP response element binding protein) in the rat suprachiasmatic nucleus is inhibited by melatonin. Neurosci Lett 227: 145-148.
49. Kopp MD, Meissl H, Dehghani F, Korf HW. 2001. The pituitary adenylate cyclase-activating polypeptide modulates glutamatergic calcium signalling: investigations on rat suprachiasmatic nucleus neurons. J Neurochem 79:161-171.
50. Kramer A, Yang FC, Snodgrass P, Li X, Scammell TE, Davis FC, Weitz CJ. 2001. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 294:2511-2515.
51. Kuhlman SJ, Silver R, Le Sauter J, Bult-Ito A, McMahon DG. 2003. Phase resetting light pulses induce Per1 and persistent spike activity in a subpopulation of biological clock neurons. J Neurosci 23:1441-1450.
52. Leak RK, Moore RY. 2001. Topographic organization of suprachiasmatic nucleus projection neurons. J Comp Neurol 433:312-334.
53. Leak RK, Card JP, Moore RY. 1999. Suprachiasmatic pacemaker organization analyzed by viral transynaptic transport. Brain Res 819:23-32.
54. Li S, Grinevich V, Fournier A, Pelletier G. 1996. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain. Brain Res Mol Brain Res 41:157-162.
55. Low-Zeddies SS, Takahashi JS. 2001. Chimera analysis of the Clock mutation in mice shows that complex cellular integration determines circadian behavior. Cell 105:25-42.
56. Lu J, Zhang YH, Chou TC, Gaus SE, Elmquist JK, Shiromani P, Saper CB. 2001. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci 21:4864-4874.
57. Lucas RJ, Cagampang FR, Loudon AS, Stirland JA, Coen CW. 1998. Expression of vasoactive intestinal peptide mRNA in the suprachiasmatic nuclei of the circadian tau mutant hamster. Neurosci Lett 249: 147-150.
58. Lutz EM, Sheward WJ, West KM, Morrow JA, Fink G, Harmar AJ. 1993. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8.
59. Lutz EM, MacKenzie CJ, Johnson M, West K, Morrow JA, Harmar AJ, Mitchell R. 1999. Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/ PACAP (PAC1) receptors. Br J Pharmacol 128:934-940.
60. Minami Y, Furuno K, Akiyama M, Moriya T, Shibata S. 2002. Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus. Neuroscience 113:37-45.
61. Moga MM, Weis RP, Moore RY. 1995. Efferent projections of the paraventricular thalamic nucleus in the rat. J Comp Neurol 359:221-238.
62. Moore RY, Danchenko RL. 2002. Paraventricular-subparaventricular hypothalamic lesions selectively affect circadian function. Chronobiol Int 19:345-360.
63. Moore RY, Speh JC, Leak RK. 2002. Suprachiasmatic nucleus organization. Cell Tissue Res 309:89-98.
64. Morin AJ, Moyse E, Denoroy L, Jouvet M. 1994. VIP binding sites in adult rat hypothalamus: nuclear distribution and daily variations. Peptides 15:117-123.
65. Morrow JA, Lutz EM, West KM, Fink G, Harmar AJ. 1993. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett 329:99-105.
66. Murase T, Kondo K, Otake K, Oiso Y. 1993. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats. Neuroendocrinology 57:1092-1096.
67. Nielsen HS, Hannibal J, Knudsen SM, Fahrenkrug J. 2001. Pituitary adenylate cyclase-activating polypeptide induces periodl and period2 gene expression in the rat suprachiasmatic nucleus during late night. Neuroscience 103:433-441.
68. Nielsen HS, Hannibal J, Fahrenkrug J. 2002. Vasoactive intestinal polypeptide induces per1 and per2 gene expression in the rat suprachiasmatic nucleus late at night. Eur J Neurosci 15:570-574.
69. Nishiwaki T, Okamura H, Kanemasa K, Inatomi T, Ibata Y, Fukuhara C, Inouye ST. 1995. Differences of somatostatin mRNA in the rat suprachiasmatic nucleus under light-dark and constant dark conditions: an analysis by in situ hybridization. Neurosci Lett 197:231-234.
70. Nomura M, Ueta Y, Serino R, Yamamoto Y, Shibuya I, Yamashita H. 1999. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei. Neuroendocrinology 69:167-180.
71. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Journot L. 1996. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271:22146-22151.
72. Peters RV, Zoeller RT, Hennessey AC, Stopa EG, Anderson G, Albers HE. 1994. The control of circadian rhythms and the levels of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus are altered in spontaneously hypertensive rats. Brain Res 639:217-227.
73. Piggins HD, Cutler DJ. 2003. The roles of vasoactive intestinal polypeptide in the mammalian circadian clock. J Endocrinol 177:7-15.
74. Piggins HD, Antle MC, Rusak B. 1995. Neuropeptides phase shift the mammalian circadian pacemaker. J Neurosci 15:5612-5622.
75. Piggins HD, Marchant EG, Goguen D, Rusak B. 2001. Phase-shifting effects of pituitary adenylate cyclase activating polypeptide on hamster wheel-running rhythms. Neurosci Lett 305:25-28.
76. Reed HE, Meyer-Spasche A, Cutler DJ, Coen CW, Piggins HD. 2001. Vasoactive intestinal polypeptide (VIP) phase shifts the rat suprachiasmatic nucleus clock in vitro. Eur J Neurosci 13:839-843.
77. Reed HE, Cutler DJ, Brown TM, Brown J, Coen CW, Piggins HD. 2002. Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro. J Neuroendocrinol 14:639-646.
78. Reppert SM, Weaver DR. 2002. Coordination of circadian timing in mammals. Nature 418:935-941.
79. Romijn HJ, Sluiter AA, Pool CW, Wortel J, Buijs RM. 1996. Differences in colocalization between Fos and PHI, GRP, VIP and VP in neurons of the rat suprachiasmatic nucleus after a light stimulus during the phase delay versus the phase advance period of the night. J Comp Neurol 372:1-8.
80. Romijn HJ, Sluiter AA, Pool CW, Wortel J, Buijs RM. 1997. Evidence from confocal fluorescence microscopy for a dense, reciprocal innervation between AVP-, somatostatin-, VIP/PHI-, GRP-, and VIP/PHI/GRP-immunoreactive neurons in the rat suprachiasmatic nucleus. Eur J Neurosci 9:2613-2623.
81. Romijn HJ, Sluiter AA, Wortel J, Van Uum JF, Buijs RM. 1998. Immunocytochemical evidence for a diurnal rhythm of neurons showing colocalization of VIP with GRP in the rat suprachiasmatic nucleus. J Comp Neurol 391:397-405.
82. Salazar-Juarez A, Escobar C, Aguilar-Roblero R. 2002. Anterior paraventricular thalamus modulates light-induced phase shifts in circadian rhythmicity in rats. Am J Physiol Regul Integr Comp Physiol 283: R897-R904.
83. Sanggaard KM, Hannibal J, Fahrenkrug J. 2003. Serotonin inhibits glutamate- but not PACAP-induced per gene expression in the rat suprachiasmatic nucleus at night. Eur J Neurosci 17:1245-1252.
84. Scarbrough K, Harney JP, Rosewell KL, Wise PM. 1996. Acute effects of antisense antagonism of a single peptide neurotransmitter in the circadian clock. Am J Physiol 270:R283-R288.
85. Schaap J, Bos NP, de Jeu MT, Geurtsen AM, Meijer JH, Pennartz CM. 1999. Neurons of the rat suprachiasmatic nucleus show a circadian rhythm in membrane properties that is lost during prolonged whole-cell recording. Brain Res 815:154-166.
86. Schibler U, Sassone-Corsi P. 2002. A web of circadian pacemakers. Cell 111:919-922.
87. Shen S, Spratt C, Sheward WJ, Kallo I, West K, Morrison CF, Coen CW, Marston HM, Harmar AJ. 2000. Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. Proc Natl Acad Sci U S A 97:11575-11580.
88. Shibata S, Ono M, Tominaga K, Hamada T, Watanabe A, Watanabe S. 1994. Involvement of vasoactive intestinal polypeptide in NMDA-induced phase delay of firing activity rhythm in the suprachiasmatic nucleus in vitro. Neurosci Biobehav Rev 18:591-595.
89. Shima T, Yagi T, Isojima Y, Okumura N, Okada M, Nagai K. 2000. Changes in circadian period and morphology of the hypothalamic suprachiasmatic nucleus in fyn kinase-deficient mice. Brain Res 870:36-43.
90. Shinohara K, Tominaga K, Isobe Y, Inouye ST. 1993. Photic regulation of peptides located in the ventrolateral subdivision of the suprachiasmatic nucleus of the rat: daily variations of vasoactive intestinal polypeptide, gastrin-releasing peptide, and neuropeptide Y. J Neurosci 13:793-800.
91. Shinohara K, Tominaga K, Inouye ST. 1998. Luminance-dependent decrease in vasoactive intestinal polypeptide in the rat suprachiasmatic nucleus. Neurosci Lett 251:21-24.
92. Shinohara K, Funabashi T, Kimura F. 1999. Temporal profiles of vasoactive intestinal polypeptide precursor mRNA and its receptor mRNA in the rat suprachiasmatic nucleus. Brain Res Mol Brain Res 63:262-267.
93. Shinohara K, Funabashi T, Nakamura TJ, Mitsushima D, Kimura F. 2002. Differential regulation of pituitary adenylate cyclase-activating peptide receptor variants in the rat suprachiasmatic nucleus. Neuroscience 110:301-308.
94. Shioda S, Shuto Y, Somogyvari-Vigh A, Legradi G, Onda H, Coy DH, Nakajo S, Arimura A. 1997a. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res 28:345-354.
95. Shioda S, Yada T, Nakajo S, Nakaya K, Nakai Y, Arimura A. 1997b. Pituitary adenylate cyclase-activating polypeptide (PACAP): a novel regulator of vasopressin-containing neurons. Brain Res 765:81-90.
96. Sollars PJ, Pickard GE. 1995. Vasoactive intestinal peptide efferent projections of the suprachiasmatic nucleus in anterior hypothalamic transplants: correlation with functional restoration of circadian behavior. Exp Neurol 136:1-11.
97. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175.
98. Stopa EG, Minamitani N, Jonassen JA, King JC, Wolfe H, Mobtaker H, Albers HE. 1988. Localization of vasoactive intestinal peptide and peptide histidine isoleucine immunoreactivity and mRNA within the rat suprachiasmatic nucleus. Brain Res 464:319-325.
99. Sylvester CM, Krout KE, Loewy AD. 2002. Suprachiasmatic nucleus projection to the medial prefrontal cortex: a viral transneuronal tracing study. Neuroscience 114:1071-1080.
100. Takahashi Y, Okamura H, Yanaihara N, Hamada S, Fujita S, Ibata Y. 1989. Vasoactive intestinal peptide immunoreactive neurons in the rat suprachiasmatic nucleus demonstrate diurnal variation. Brain Res 497:374-377.
101. Tanaka M, Okamura H, Matsuda T, Shigeyoshi Y, Hisa Y, Chihara K, Ibata Y. 1996. Somatostatin neurons form a distinct peptidergic neuronal group in the rat suprachiasmatic nucleus: a double labeling in situ hybridization study. Neurosci Lett 215:119-122.
102. Tanaka M, Amaya F, Tamada Y, Okamura H, Hisa Y, Ibata Y. 1997. Induction of NGFI-A gene expression in the rat suprachiasmatic nucleus by photic stimulation. Brain Res 756:305-310.
103. Teclemariam-Mesbah R, Kalsbeek A, Pevet P, Buijs RM. 1997. Direct vasoactive intestinal polypeptide-containing projection from the suprachiasmatic nucleus to spinal projecting hypothalamic paraventricular neurons. Brain Res 748:71-76.
104. Teclemariam-Mesbah R, Ter Horst GJ, Postema F, Wortel J, Buijs RM. 1999. Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway. J Comp Neurol 406:171-182.
105. Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. 2002. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci U S A 99:7728-7733.
106. Uhl GR, Reppert SM. 1986. Suprachiasmatic nucleus vasopressin messenger RNA: circadian variation in normal and Brattleboro rats. Science 232:390-393.
107. Usdin TB, Bonner TI, Mezey E. 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662-2680.
108. Watanabe K, Yamaoka S, Vanecek J. 1998. Melatonin inhibits spontaneous and VIP-induced vasopressin release from suprachiasmatic neurons. Brain Res 801:216-219.
109. Watanabe K, Vanecek J, Yamaoka S. 2000. In vitro entrainment of the circadian rhythm of vasopressin-releasing cells in suprachiasmatic nucleus by vasoactive intestinal polypeptide. Brain Res 877:361-366.
110. Watts AG, Swanson LW. 1987. Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 258:230-252.
111. Yamase K, Takahashi S, Nomura K, Haruta K, Kawashima S. 1991. Circadian changes in arginine vasopressin level in the suprachiasmatic nuclei in the rat. Neurosci Lett 130:255-258.
112. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M, Tei H. 2000. Resetting central and peripheral circadian oscillators in transgenic rats. Science 288:682-685.
113. Yan L, Okamura H. 2002. Gradients in the circadian expression of Per1 and Per2 genes in the rat suprachiasmatic nucleus. Eur J Neurosci 15:1153-1162.
114. Zhou CJ, Yikuyama S, Arimura A, Shioda S. 2000. Distribution of PACAP receptor and its splice variants in the rat brain by in situ RT-PCR. Ann N Y Acad Sci 921:373-374.